Aspirin noncompliance is the major cause of “aspirin resistance” in patients undergoing coronary stenting
- 31 May 2009
- journal article
- research article
- Published by Elsevier BV in American Heart Journal
- Vol. 157 (5), 889-893
- https://doi.org/10.1016/j.ahj.2009.02.013
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Incidence and Clinical Impact of Dual Nonresponsiveness to Aspirin and Clopidogrel in Patients With Drug-Eluting StentsJournal of the American College of Cardiology, 2008
- Aspirin “resistance” and risk of cardiovascular morbidity: systematic review and meta-analysisBMJ, 2008
- High post‐treatment platelet reactivity identified low‐responders to dual antiplatelet therapy at increased risk of recurrent cardiovascular events after stenting for acute coronary syndromeJournal of Thrombosis and Haemostasis, 2006
- Compliance as a critical consideration in patients who appear to be resistant to aspirin after healing of myocardial infarctionThe American Journal of Cardiology, 2005
- Narrative Review: Aspirin Resistance and Its Clinical ImplicationsAnnals of Internal Medicine, 2005
- Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatmentJournal of the American College of Cardiology, 2004
- A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular diseaseJournal of the American College of Cardiology, 2003
- Aspirin-Resistant Thromboxane Biosynthesis and the Risk of Myocardial Infarction, Stroke, or Cardiovascular Death in Patients at High Risk for Cardiovascular EventsCirculation, 2002
- Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment ElevationNew England Journal of Medicine, 2001
- Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE studyThe Lancet, 2001